Supplementary Material for: SARS-CoV-2-induced remission of chemotherapy resistance B-cell non-Hodgkin lymphoma: A case report

Introduction: Investigation on virus-host interaction may provide new clues for anti-tumor immunotherapy. Case presentation:In this case report we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission. Conclusion: Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based anti-tumor immune therapy in the future.